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1. INTRODUCTION
Chlorpheniramine maleate (CPM) is a first generation 
alkyl amine widely used as antihistamine drug patients to 
inhibit various histaminic actions in the body principally 
through a reversible competitive antagonism of histamine 
at the receptor sites [1]. Apart from the most common side 
effects possess by all the antihistamines, CPM has a major 
problem related to its oral bioavailability [2]. however, 
it is well absorbed from the gastrointestinal tract, its oral 
bioavailability is only 25-40% of the orally administered 
dose which is due to its high first pass metabolism [4]. 
Investigations have shown that desmethylchlorpheniramine 
(DMCP) and didesmethylchlorpheniramine (DDMCP) are 
the major by-products of chlorpheniramine (CP) metabolism 
in the liver which decreases its bioavailability [3].
unit dosage forms such as tablets and capsules are widely and 
ABSTRACT
Many conventional dosage form comes in market to achieve 
their therapeutic value as it administered through the given 
route. But sometimes People feel trouble in swallowing of 
conventional dosage forms like tablet and capsule without 
taking water or due to lack availability of water during long 
journey.  In these cases, rapidly disintegrating tablets in oral 
cavity are paid attention nowadays. These are known as orally 
dispersible tablets which disintegrate in mouth as put on tongue 
resulting in release of drug which dissolve and disperse in saliva. 
Drug rapidly converts into solution from solid form resulting 
in rapid absorption and onset of action. After formulations 
development, evaluation of these tablets were done such as 
weight variation, hardness, friability, disintegration, drug-
polymer interaction, FTIR studies, SeM studies, drug content, 
water absorption ratio, wetting time and in-vitro drug release 
and short term stability studies. These tablets (all formulations 
that is F1-F10) showed weight variation in range of 253± 0.05 
to 291± 0.61 mg, hardness of 2.1± 0.1 to 3.5± 0.07 Kg/cm², 
friability of 0.44±0.01 to 0.69±0.01%, disintegration time of 20± 
0.08 to 34±1.1 seconds, drug content of 92.0 to 99.18%, water 
absorption ratio of 26±1.12 to 49 ± 3.01 %, wetting time of 53± 
1.89 to 104± 4.89 sec and in-vitro drug release showed 85.66 
to 99.88% within 5 minutes. FTIR studies showed that there 
is no interaction between drug and polymer. Stability studies 
showed that there is no change in drug release upon storage on 
different temperature and humidity. Results revealed that orally 
dispersible tablets of chlorpheniramine maleate prepared by 
fusion method result in rapid dissolution.  
Keywords: Chlorpheniramine maleate; Fusion method; FTIR; 
SeM; Full factorial design. 
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successfully utilized due to their simplicity but dysphagia and 
difficulty in swallowing are their major drawbacks among 
pediatric, geriatric, bed ridden patients or even those who are 
travelling and have little access to water [4-6]. Research and 
development cells of many Government and pharmaceutical 
companies are in constant quest of designing and improving 
a satisfactory formulation [6] which could overcome the 
problems like; poor solubility/or poor bioavailability of active 
pharmaceutical compounds; overcoming unpleasant taste 
of API’s and excipients; reducing dose frequency; difficulty 
in swallowing; fluctuations in plasma drug concentration 
profile etc. to overall improve patient compliance [5].
The ability of fast tablet disintegration and dissolution to 
guarantee rapid availability of the drug(s) for oral absorption 
has been widely studied, understood and commercially 
manipulated [4]. Orally dispersible tablets (ODT’s) have been 
found to be the dosage form of choice for patients suffering 
from nausea, vomiting or motion sickness.
The problem of low mechanical hardness associated with 
the development of ODTs is tackled by use of specialized 
primary packaging such as double-foil blister pack with a 
peelable aluminum lidding [1-2]. Disintegrants are one of 
the prominent excipients which play a crucial role in the 
formulation of ODT’s because mechanical and disintegrating 
property predominantly depends on it. An efficient 
disintegrant may provide rapid disintegration due to the 
combined effect of swelling and water absorption by the 
formulation [3]. A very few approved disintegrants are for the 
formulators for pharmaceutical industries. First generation 
disintegrants are starches (e.g., corn starch, potato starch) and 
cellulose based disintegrants (e.g., microcrystalline cellulose, 
low substituted hydroxypropyl cellulose). The need for 
shorter disintegration times or more efficient disintegrants 
led to the development of superdisintegrants such as 
modified cellulose like croscarmellose sodium (CCS), cross-
linked polyvinylpolypyrrolidone or crospovidone (CPD) and 
modified starches like sodium starch glycolate (SSG) [3]. 
Microcrystalline cellulose (MCC), a widely used cellulose 
based excipient imparts improved flow, compaction 
properties and exceptionally strong binding property. Its 
good disintegration property is attributed to swelling or 
capillary action and high dilution potential [9-10] studied the 
feasibility of MCC within ODT’s as a binder due to its high 
compactable and pleasant taste upon tablet disintegration [9]. 
Croscarmellose (CCS) is a cross-linked polymer of 
carboxymethyl cellulose sodium. The cross-linked structure 
renders the polymer insoluble. The sodium carboxymethyl 
groups of CCS, however, enable the polymer to wick relatively 
large amounts of water into its matrix, causing the polymer to 
swell rapidly. When CCS is used in tablets, this swelling force 
facilitates the tablet disintegration. 
Crospovidone (CPD), a synthetic disintegrant is widely used 
in ODT’s to enhance the fast disintegration of ODT’s which 
works on the mechanism of capillary action and swelling 
ability [9] due to presence aggregates of sponge-like porous 
structure as revealed by microscopic imaging [4]. A wide 
variety of cationic, anionic and non-ionic drugs can be 
delivered in formulations containing CPD due to its neutral 
characteristics [1]. CPD when used in high concentrations 
has dual functionality of as a binder disintegrant system due 
to its ability to reduce friability of the tablet considerably 
together with reduction in disintegration time [2]. 
There are various techniques for formulating orally 
dispersible tablets such as lyophilization, direct compression, 
tablet molding, sublimation, and fusion etc. In the present 
study, orally dispersible tablets of CPM were prepared by 
fusion method and superdisintegrants such as CCS, CPD 
and MCC have been utilized for faster disintegration. The 
aim of the study is to achieve objectives like enhanced patient 
compliance, increased bioavailability, rapid onset of action, 
convenience in administration, good mouth feels etc.
2. MATERIALS AND METHODS
2.1. Materials
CPM was obtained from MP Biomedicals, Mumbai, India, 
CCS and CPD were gifted from Dr. Reddy’s laboratory, 
hyderabad, India, PeG 6000 and SSG were obtained from 
hiMedia Pvt. Ltd., Mumbai, India, mannitol was obtained 
from Central Drug house Pvt. Ltd., Mumbai, India, and 
microcrystalline cellulose was obtained from Merck, India. 
All other reagents and chemicals used were of analytical grade.
2.2. Formulation method of ODT’s by fusion method
In this study, ODT’s containing CPM were prepared by 
fusion method according to the formulae given in Table 1. 
To prepare different batches, all ingredients according to 
the formula were accurately weighed and passed through 
60 and 100 mesh sieve and mixed geometrically. Accurately 
weighed quantities (300 mg) of this physical mixture were 
filled in blisters, properly wrapped with aluminum foil and 
kept in hot air oven for about 45 minutes at a temperature of 
55ºC. Finally, the blisters were withdrawn from oven, cooled 
to room temperature and ODT’s separated and stored in 
desiccator [11]. 
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2.3. Measurement of tablet tensile strength and friability
The ability to withstand mechanical shock of handling in 
manufacturing, packaging and shipping is measured in 
terms of tensile strength or crushing load and friability. The 
crushing load for ODT’s of various batches were determined 
by compressing the tablets in diametric direction using a 
Pfizer tablet hardness tester (Cadmach, India) [12]. The 
friability of tablets was determined using Roche Friabilator 
uSP test apparatus (electrolab, Mumbai).  Randomly six 
ODT’s were chosen from each batch and their initial weight 
was determined Table 2. The ODT’s were placed in Friabilator 
and rotated at 25 rpm for 4 minutes. The tablets were 
removed, dusted and their final weight was determined [13]. 
The formula for calculating friability is given in equation 1 as:
  
       eq. 1
Where, Wi is initial weight and Wf is the final weight of the 
tablets.
2.4. Measurement of disintegration time
The in-vitro disintegration time of formulated ODT’s was 
determined using digital disintegration apparatus (electrolab, 
Mumbai, India) using 900 ml of ph 6.8 phosphate buffer at 
37±0.5ºC. Six tablets from each batch were randomly chosen 
and the average time for complete disintegration of these 
tablets was determined (Table 2). [9-10]. All ODT’s under test 
took 20-34 sec to disintegrate completely. Low disintegration 
time was achieved as a result of using two superdisintegrants 
CCS and CPD [14-16]. 
2.5. Wetting time and Water absorption ratio
To determine the wetting time of ODT’s, a piece of tissue 
paper was taken and it was folded twice and placed in culture 
dish (d = 6.5 cm) containing about 6ml of purified water. 
An ODT having small amount of amaranth powder on 
upper surface was placed on tissue paper. The time elapsed 
in developing red color on upper surface of the ODT was 
determined and noted. To determine the water absorption 
ratio, the wetted tablets were transferred to a tissue paper and 
wiped off any excess water and weighed immediately [17]. 
Results are presented in Table 3. The water absorption ratio 
was calculated by following formula given in equation 2 as:
    eq. 2
Where, Wb is the weight of tablet before study and Wa is the 
weight of tablet after study [19].
2.6. Weight variation and tablet thickness
Twenty tablets were randomly taken from each batch and 
their average weight was determined. Then individual tablet 
was taken and its weight was calculated. That individual 
weight was compared with average weight.  The weights 
were measured using weighing balance [18]. Twenty tablets 
were randomly selected from formulations and thickness 
was measured individually by screw gauge. The results were 
expressed in millimeters (Table 2) [19-21].
Table 1.  Composition of ODT’s by fusion method
Ingredients (mg)
Batch
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10
Chlorpheniramine maleate 50 50 50 50 50 50 50 50 50 50
Sodium starch glycolate 10 20 30 10 10 10 10 10 10 10
Microcrystalline cellulose 40 40 40 60 40 40 60 40 40 40
Mannitol 100 110 80 60 70 60 30 70 80 80
Croscarmellose sodium    _    _ 10 20 30 30 40 30 20 10
Crospovidone    _    _ 10 20 20 30 30 20 20 30
PeG 6000 100 80 80 80 80 80 80 80 80 80
Total 300 300 300 300 300 300 300 300 300 300
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2.7. Drug content of solid dispersion 
Three tablets were randomly chosen from each batch, 
crushed and the blend equivalent to 5.0 mg of CPM was 
accurately weighed and transferred to 100 ml volumetric 
flask.  Then 20 ml of Phosphate buffer (ph 6.8) was added 
under continuous stirring and volume was made up to 100 
ml with the same. The solutions were filtered and analyzed 
spectrophotometrically at 261 nm [19]. Measurements were 
performed in triplicate.
Table 2. evaluation of ODT’s by fusion method
Test F1 F2 F3 F4 F5 F6 F7 F8 F9 F10
Wt. variation 
(mg) 291±0.16 290±0.34 288±0.40 285±0.14 282±0.09 274±0.01 270±0.07 268±0.05 261±0.03 293±0.05
Hardness 
(Kg/cm²) 3.5±0.07 3.4±0.05 3.3±0.01 2.8±0.02 3.2±0.09 3.1±0.12 3.0±0.31 2.5±0.35 2.3±0.18 2.1±0.23
Friability (%) 0.69±0.01 0.68±0.12 0.65±0.30 0.62±0.30 0.60±0.12 0.56±0.31 0.52±0.08 0.48±0.05 0.47±0.03 0.44±0.01
Drug content 
(%) 92 94.5 95.2 96.6 97.1 98.02 98.05 98.99 99.05 99.18
Thickness 
(mm) 9.03±0.12 9.85±0.11 9.84±014 9.15±0.74 9.90±0.22 10.2±0.24 10.32±0.24 10.43±0.11 10.5±0.12 10.89±014
*All data expressed as mean ± S.D.; 𝑛 = 3; 𝑃 ≤ 0.05.
2.8. Fourier Transform Infrared (FTIR) spectroscopy
The FTIR spectroscopy of pure drug, CPM, the solid 
admixture of drug and various excipients in 1:1 ratio used 
in the formulations as well as the ODT’s were characterized 
by KBr pellet method using Perkin elmer FTIR Series 
model-1615 spectrophotometer to know the compatibility 
and interactions. The FTIR spectra are shown in Fig 1. The 
FTIR study did not show any possible interaction between 
CPM and superdisintegrants used in the orally dispersible 
tablets.
Fig 1. FT-IR of CPM and other excipients
2.9. Scanning electron microscopy (SEM)
The scanning electron microscopy was used to determine 
the morphological appearance of the formulated ODT’s. The 
coating of ODT’s was done using gold for 10 minutes with the 
use of fine coat ion-sputter and examined under Fe-SeM (JSM 
6701; JeOL, Japan). Signals of electron-sample interactions 
reveal information about sample including crystalline 
structure, chemical composition, external morphology etc. 
A variety of signals at the surface of solid specimens were 
recorded Fig 2a and 2b. The data was collected from ODT’s 
and 2-dimensional images were generated that displayed 
spatial variations in these properties. 
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Fig 2. SeM micrograph of formulated ODT’s (a) at x4500 (b) 
at x5000
2.10. Differential scanning calorimetry (DSC)
DSC (NeTZSCh DSC 204- F1 phoenix, u.S.) thermograms 
of pure drug CPM, excipients used in formulations and ODT’s 
is presented in Fig 3. DSC provides information regarding 
the physical properties like degree of drug crystallinity and 
amorphous nature of the samples. Approximately 2-4 mg of 
sample was taken in an aluminum pan which was heated at a 
scanning rate of 20 C̊/min for a temperature of -50 to 220ºC. 
The peak area of melting endotherm was used for calculating 
heat of fusion. The Proteus software provided with the 
instrument was used to calculate the thermal peaks [22].
Fig 3. Combined DSC thermogram of CPM, excipients and 
formulated ODT
2.11. Thermogravimetric analysis (TGA)
TGA is a technique which helps in monitoring function of 
temperature or time as sample is subjected to controlled 
temperature program in a controlled atmosphere. It is a 
technique in which upon heating a material, its weight 
increases or decreases. TGA of CPM is shown in Fig. 4 [23-
24].
Fig 4. TGA of a) pure drug CPM, b) formulated ODT’s
2.12. In-vitro dissolution studies
The in-vitro dissolution studies of the formulated ODT’s were 
studied in uSP dissolution apparatus type II (Tab Machines, 
Mumbai, India) with a paddle stirrer at 50 rpm filled with 
900 ml ph 6.8 phosphate buffer at 37±0.5ºC. ODT’s were 
placed in basket and program was set for a duration of 
five minutes. Aliquots of dissolution media (2 ml) were 
withdrawn initially and at every 1 minute and replaced with 
fresh dissolution media. The samples were filtered through 
a 0.45µ filter membrane (Millipore, County Cork, Ireland) 
and absorbance was measured spectrophotometrically at λmax 
261nm. The dissolution test was carried out in triplicate and 
are presented in Fig 5 [23-25].
Fig 5. Dissolution graph of formulated ODT’s
2.13. Response surface methodology
Response surface methodology (RSM) have proved to be 
useful statistical and mathematical techniques in modeling 
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and process optimization of experimental variables which 
influences relevant responses and the objective of this 
research is to optimize these responses [25]. RSM explores 
the relationships between several independent variables 
(factors) and one or more dependent variables (responses) 
[26]. This design is very flexible and suitable for modeling 
possible curvature in the response functions and constructing 
second order polynomial models moreover a third level for 
a continuous factor facilitates investigation of quadratic 
relationship between the response and each of the factors 
(NIST/SeMATeCh 2015).
Ten ODT formulations were prepared and the effect of 
independent variables on responses (dependent factors) were 
evaluated using RSM and are presented in Fig 6 [27-28]. Two 
independent variables were selected: the content of CPD (CP, 
X1) and CCS (CM, X2) and each variable was tested at different 
concentrations, the quantities of which are expressed in their 
respective units [28-29]. The responses evaluated were: drug 
dissolution (%DR, Y1), disintegration time (DT, Y2), and 
water absorption ratio (WAR, Y3) and wetting time (WT, Y4). 
experiments were performed according to a randomized 
procedure and the scheme showing the values of process 
variables corresponding to the observed responses is reported 
in Table 3. Statistica V.10_ software (StatSoft, Inc. uSA) was 
used for generation and evaluation of response surfaces.
Fig 6. Response surface plots showing effect of concentration 
of CCS and CPD on measured responses (a) Drug dissolution 
(%), (b) Disintegration time (Sec.), (c) Water absorption 
ratio, (d) Wetting time (Sec.).
Table 3. Process variables and their corresponding measured responses
Batch Croscarmellose(mg)
Crospovidone
(mg)
Drug
dissolution
(%)
Disintegration
time (seconds)
Water absorp-
tion
ratio
Wetting time 
(sec)
F1 - - 64.67±1.60 34±1.1 26±1.12 53±1.89
F2 - - 72.09±0.67 31±1.35 28±1.34 56±1.0
F3 10 10 78.78±1.49 29±1.08 29±1.40 100±1.45
F4 20 20 81.56±1.07 27±1.42 30±1.20 73±1.08
F5 30 20 86.23±0.89 25±1.12 32±1.09 78±2.01
F6 30 30 90.12±0.2 24±1.4 36±1.59 88±2.98
F7 40 30 92.23±0.35 23±1.32 43±2.01 94±3.09
F8 30 20 93.23±2.13 22±1.21 45±2.06 98±3.34
F9 20 20 95.45±2.36 21±1.02 48±2.46 102±4.09
F10 10 30 96.85±2.76 20±0.08 49±3.01 104±4.89
*All data expressed as mean ± S.D.; 𝑛 = 3; 𝑃 ≤ 0.05.
2.14. Stability studies 
The capability of dosage form to continue with its physical, 
chemical, therapeutic and toxicological specifications is 
known as stability. For evaluation of dosage forms, stability 
is an important tool which provides information regarding 
acceptance or rejection of these dosage forms [32-33].  
3. RESULTS AND DISCUSSION 
Response surface methodology 
Fourier Transform Infrared (FTIR) spectroscopy
The pure drug CPM and solid admixture of drug and 
various excipients with formulation were characterized by 
FTIR spectroscopy for testing compatibility of CPM with its 
polymers and formulation. The IR transmission spectra of 
drug, polymers and formulation are given in Fig 1. All the 
peaks were presented in their original position which shows 
that there is no drug-carrier interaction. The characteristic 
peak of CPM is 3250 cm-1 due to its amino group i.e. N-h 
stretching. Other characteristic peaks present were 1580 cm-1 (C=C 
stretching), 1475 cm-1 (C=C stretching), 864 cm-1 (C-h stretching), 
1352 cm-1 (C-C bending), 1697 cm-1 (–C=O stretching), 1576 cm-1 
(C-N stretching), 702 cm-1 (C-Cl stretching). Similarly, the polymer 
used in formulation showed its characteristic peaks which are 
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separate from drug which showed that drug was compatible with 
polymer and leads to good stability. The CCS showed its peaks 
such as 3430 cm-1 (–Oh strecthing), 1740 cm-1, 1611 cm-1 (C=O 
stretching).
Scanning electron microscopy (SEM)
The change in morphological appearance of drug was studied 
using scanning electron microscopy. The SeM micrographs 
showed that presence of excipients such as CCS, CPD and 
PeG 4000 influence the surface morphology of ODT’s and 
pure drug. The surface morphology of ODT’s demonstrated 
hard but rough and fragmented fibrous network like 
structures. Several regions on surface showed randomly 
scattered spherical particles of drug whereas excipients 
showed rough material structures.
Differential scanning calorimetry (DSC)
The DSC thermogram of pure drug CPM shows sharp 
endothermic peak at 139ºC indicating its melting point. The 
glass transition of CPM was 41.04ºC. There is lack of drug peak 
in the thermogram of ODT showing that CPM was completely 
dissolved with the excipients and is present partially in crystalline 
and partially as molecular distribution. The thermograms of 
CCS and CPD indicated their melting points at 300ºC and 83ºC 
respectively and were according to their melting range. There 
was lack of glass transition temperature in thermogram of any 
excipients and also in ODT’s. 
Thermogravimetric analysis (TGA)
In this analysis, the drug CPM and formulated ODT’s were 
subjected to controlled temperature program in a controlled 
atmosphere. In TGA graph of CPM showed that the mass 
remained constant with increasing temperature but when 
it approached to melting point of drug, the mass started to 
decrease. Similar phenomenon was also observed with the 
formulated ODT’s. The thermogram of ODT showed three 
endotherms which are probably the melting points of CPM 
at 139ºC, SSG peak at 200ºC, MCC at 270ºC which revealed 
that excipients or moisture content have no adverse effect on 
formulations.
Disintegration time
The disintegration data of the ODT’s has shown in Table 3. 
The ODT’s formulated with 10 mg of SSG without addition 
of CCS and CPD showed extremely slow disintegration of 
34 seconds. Whereas faster disintegration rate of 23 seconds 
was observed in ODT’s (F7) containing CCS and CPD in a 
quantity of 40 mg and 30 mg but not to the level which is 
required in disintegration of ODT’s. This behavior is due to 
presence of CCS which swells in the presence of water. Thus, 
quantity of CCS was decreased and CPD was increased in 
formulation F10 which contains CCS 10 mg and CPD 30 mg 
which was the best optimized formulation and showed faster 
disintegration of 20 seconds.
In-vitro dissolution studies
The in-vitro dissolution studies of the formulated ODT’s 
were performed to evaluate the effect of CCS, CPD and SSG 
on release pattern of CPM. The dissolution rate of ODT’s 
without CCS and CPD was extremely slow. Only about 19.8% 
drug was released in 1 minute and 64.67% drug was released 
in 5 minutes. But when CCS and CPD were incorporated 
then drug release reached 92.23% in 5 minutes which is not 
sufficient for a formulation like ODT’s. This behavior may 
be attributed to swelling of CCS which forms a gel like mass 
entrapping some of the drug and prevents its release. When 
quantity of CPD is increased and CCS is decreased in F10, 
then 96.85% drug was released in 5 minutes. The above 
results indicate that ODT’s containing 10 mg CCS and 30 
mg CPD are the most optimized formulation in respect of 
CPM release. Also effect of various polymers on dissolution 
behavior was evaluated. After evaluating, it was determined 
that CCS and CPD performed better than SSG. 
Response surface analysis
The response surface models fit between the factors and 
measured responses is shown in the equations given below:
%DissoCP, CM=32.717-0.447CPD-0.00383CPD2-0.153CCS-
0.00783CCS2+0.0215CPD*CCS
Dist.TimeCP, CM=68.13217+1.336CPD-0.00389CPD2+0.11CCS 
+0.0158CCS2-0.0351CPD*CCS 
WARCP, CM=26.3+1.87CPD-0.018CPD2-1.02CCS+0.038CCS2-
0.036CPD*CCS
WTCP, CM=56.87+8.73CPD-0.2037CPD2-4.83CCS+0.0703CCS
2+0.0327CPD*CCS
The response surface plots representing the relationship 
between the studied factors and measured responses is 
demonstrated in Fig 6A-6D.
The different batches of CPM ODT’s were prepared by fusion 
method using superdisintegrants CCS and CPD and also in 
different polymer concentrations and all formulations were 
evaluated. [43-48]. Total of 10 formulations with different 
concentrations of excipients and fixed concentration of 
drug were evaluated. Weight variation of all formulations 
was observed in range of 253 to 291 mg which was within 
acceptable limit for uncoated tablets as per uSP. ODTs (batch 
F1 to F10) showed weight variation, thickness of 9.03 mm 
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to 10.89 mm, drug content of 92.0 to 99%, water absorption 
ratio of 26 to 49%, wetting time of 53 to 104 sec and in-vitro 
drug release showed 64.67 to 96.85% within 5 minutes. The 
best optimized formulations (F9 and F10) showed best results 
from all formulations. In both, F10 is the most optimized 
formulation which showed disintegration time of 20 
seconds. All the formulations were evaluated using different 
evaluation parameters. First evaluation parameter was weight 
variation which was performed with all 10 formulations. 
Weight variation was observed within the acceptable limits 
for ODT’s as per uSP. The primary requirement of ODT’s 
is rapid disintegration. Angle of repose (Ө) determines the 
internal friction and cohesion of particles. If value of angle of 
repose is higher, then it shows greater cohesiveness of powder 
but if its value is low, it shows non-cohesiveness of powder. 
All formulations showed good to acceptable flow properties 
as indicated by values of angle of repose (30.31-39.28). Carr’s 
index showed values up to 20 which denote acceptable to 
good flow ability. All formulations had hausner’s ratio values 
within the stated limit.  If the crushing strength (hardness) 
of ODT’s is higher, it takes longer time to disintegrate. So 
the most important factor in formulation of ODT’s is their 
mechanical integrity. The hardness of tablets was found 
to be in the range of 2.1 to 3.5 Kg/cm² and friability was 
observed 0.44 to 0.69% which were also within acceptable 
limits. The disintegration time was observed between 20 
to 34 sec. Disintegration test showed that formulations in 
which CCS and CPD were used showed rapid disintegration. 
But formulation in which CCS was added in quantity more 
than 10 mg showed longer disintegration. This is due to 
rapid uptake of water from the medium. Due to swelling 
disintegration time decreases. Thus, the most optimized 
formulation containing 10 mg CCS, 30 mg CPD showed 
rapid disintegration. Thus, CCS was considered as optimum 
disintegrant. Percentage drug content and wetting time were 
also observed which were found to be within acceptable limits. 
It was found that in case of optimized formulation 32.12% 
drug was released in first 2 minutes. But in five minutes, 
about 96.85% of drug was released. Thus, superdisintegrants 
played the most important role in enhancing drug release. 
Thus formulation 10 was considered the best formulation. 
Now the FTIR spectra showed that there is no interaction 
between CPM and different excipients. Thus, it could be 
concluded that the superdisintegrants based ODT’s of CPM 
showed fast disintegration, quick drug release and faster 
onset of action. The formulations containing CCS showed 
rapid disintegrating time of 20 seconds this is due to rapid 
uptake of water from the medium swelling and burst effect, 
there was the direct correlation between wetting time and 
disintegration time and there was no erosion on the tablet 
surface take placed during study of the wetting time. Thus. 
it was found that the formulation containing CCS showed 
rapid wetting time and disintegration time compared to 
other super disintegrants.
Stability studies 
The stability studies were carried out according to ICh 
guidelines for one month for accelerated study at 40 ± 2 oC and 
Rh 75 % ± 5 %. The tablets were withdrawn after a period of 
30 days and analyzed for physical characterization and drug 
content. Results are presented in Tables 4. The ODT’s tablets 
were divided into three batches and kept at three different 
temperature at room temperature 25±2ºC/60 ±5% Rh, at 
accelerated temperature 40 ± 2ºC/75 ± 5% Rh and at cool 
temperature 4 ± 2ºC/65 ± 5% Rh as a function of time 30days 
and 60days respectively. Then each sample was withdrawn 
at specific time (as mention in protocol) and then the drug 
release studies was performed. According to the observation it 
was observed that the sample stored at room temperature were 
shown a satisfactory drug release after a storage time of 30 
and 60 days i.e. 80.91± 0.81% and 80.30± 1.63% respectively. 
While, the samples stored at accelerated and cool temperature, 
results in decrease in % drug release. hence, we can concluded 
that room temperature is suitable for the storage condition of 
Chlorpheniramine maleate ODT. All the analyses were carried 
out in triplicate and the results are reported as mean ± SD.
Table 4. Stability study data of ODT
S. no. Month (days) Stability conditions Condition values Release in 5 min (%)Formulation F10
1. 30
Room temperature (25 ± 2ºC/60 ±5% Rh) 80.91± 0.81
Accelerated temperature (40 ± 2ºC/75 ± 5% Rh) 79.80± 0.71
Cool temperature (4 ± 2ºC/65 ± 5% Rh) 76.17± 0.12
2. 60
Room temperature (25 ± 2ºC/60 ± 5% Rh) 80.30 ± 1.63
Accelerated Temperature (40 ± 2ºC/75 ± 5% Rh) 72.80± 0.77
Cool temperature (4 ± 2ºC/65 ± 5% Rh) 74.90± 0.70
*All data expressed as mean ± S.D.; 𝑛 = 3; 𝑃 ≤ 0.05.
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Conclusion
From the above work it was concluded that the release 
of drug from the F9 and F10 formulation was quick when 
compared to F1-F8. It showed that the combined effect 
of CCS and CPD gives synergistic effect. Thus, various 
superdisintegrants and application of the fusion method 
enhance dissolution, absorption, bioavailability, stability 
of ODT’s and also manifold advantages of ODT’s enhance 
patient compliance, decrease side effect of conventional 
dosage forms and increase its popularity in near future. It 
may be concluded that from the DSC, FTIR, drug content 
and in-vitro dissolution studies, ODT of F10 prepared by 
fusion method is the best formulation. As CPM is highly 
water soluble drug but it metabolizes in liver due to which 
its bioavailability decreases. But by formulating its ODT’s, 
this problem can be eliminated. Thus a tablet with rapid 
dissolution and rapid absorption is formulated for rapid 
action within few minutes.
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Füzyon Yöntemiyle hazırlanan klorfeniramin maleat içeren 
ağızda dağılan tabletlerin formülasyonu ve değerlendirilmesi
 
ÖZ
Ticari ürün olarak klinik kullanıma sunulan birçok ilaç veriliş 
yolunma bağlı olarak terapötik değer kazanmaktadır. İnsanlar 
tablet ve kapsül gibi konvansiyonel dozaj formlarını, yolculuk 
gibi nedenlerle  su bulamadıkları  zamanlarda yutmakta 
zorlanmaktadırlar. Bu gibi durumlarda kullanılmak üzere 
ağız boşluğunda hızla dağılan tabletler dikkati çekmektedir. 
Ağızda dağılan tabletler, dil üzerine yerleştirildiğinde dozaj 
formu tükürük vasıtasıyla dağılmakta ve ilaç çözünmektedir. 
Katı formdaki ilaç hızla çözeltiye dönüşmekte ve bu durum 
ilacın emilimini ve etkinin başlamasını hızlandırmaktadır. 
Formülasyonlar hazırlandıktan sonra elde edilen tabletler; 
ortalama tablet ağırlığı ve ağırlık tekdüzeliği, sertlik, ufalanma-
aşınma, dağılma zamanı, ilaç-polimer etkileşimleri, etken 
madde içeriği, su emme oranı, in-vitro ilaç salım özellikleri 
ve kısa süreli stabilite özellikleri açısından değerlendirilmiş, 
FTIR çalışmaları ve SeM çalışmaları yapılmıştır.  F1-F10 olarak 
isimlendirilen tüm formülasyonların ortalama tablet ağırlığı 
ve ağırlık tekdüzeliği 253± 0.05 - 291± 0.61 mg, sertliği 2.1± 
0.1 - 3.5± 0.07 Kg/cm², ufalanma-aşınma yüzdesi % 0.44±0.01 
- 0.69±0.01, dağılma zamanı 20± 0.08 -  34±1.1 saniye, etken 
madde içeriği % 92.0 - 99.18, su emme oranı  26±1.12 - 49 ± 
3.01, ıslanma zamanı 53± 1.89 - 104± 4.89 saniye ve 5 dakika 
içerisinde in-vitro ilaç salım yüzdesi % 85.66 -99.88 olarak 
belirlenmiştir. FTIR çalışmaları, ilaç ve polimer arasında bir 
etkileşim olmadığını göstermiştir. Stabilite çalışmaları ilacın 
farklı sıcaklık ve nem ortamında saklandığında ilaç salım 
özelliğinin değişmediğini göstermiştir. elde edilen sonuçlar 
füzyon yöntemiyle hazırlanan ve klorfeniramin maleat içeren 
ağızda dağılan tabletlerin hızlı dissolüsyona uğradığını 
göstermiştir.
Anahtar kelimeler: Klorfeniarmin maleat, füzyon yöntemi, 
FTIR, SeM, Tam Faktöriyel Tasarım
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